These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 8455638)

  • 1. Insertion of constant region domains of human IgG1 into CD4-PE40 increases its plasma half-life.
    Batra JK; Kasturi S; Gallo MG; Voorman RL; Maio SM; Chaudhary VK; Pastan I
    Mol Immunol; 1993 Mar; 30(4):379-86. PubMed ID: 8455638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model.
    Kreitman RJ; Chang CN; Hudson DV; Queen C; Bailon P; Pastan I
    Int J Cancer; 1994 Jun; 57(6):856-64. PubMed ID: 8206679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.
    Wang QC; Pai LH; Debinski W; FitzGerald DJ; Pastan I
    Cancer Res; 1993 Oct; 53(19):4588-94. PubMed ID: 8402632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors.
    Ogata M; Lorberboum-Galski H; FitzGerald D; Pastan I
    J Immunol; 1988 Dec; 141(12):4224-8. PubMed ID: 3264309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interdomain interactions in the chimeric protein toxin sCD4(178)-PE40: a differential scanning calorimetry (DSC) study.
    Davio SR; Kienle KM; Collins BE
    Pharm Res; 1995 May; 12(5):642-8. PubMed ID: 7479546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor alpha within Pseudomonas exotoxin as a targeting ligand.
    Kreitman RJ; Chaudhary VK; Siegall CB; FitzGerald DJ; Pastan I
    Bioconjug Chem; 1992; 3(1):58-62. PubMed ID: 1616950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of CD4-Pseudomonas exotoxin against cells expressing diverse forms of the HIV and SIV envelope glycoproteins.
    Ashorn P; Moss B; Berger EA
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):70-7. PubMed ID: 1738090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catabolism of the murine IgG1 molecule: evidence that both CH2-CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice.
    Kim JK; Tsen MF; Ghetie V; Ward ES
    Scand J Immunol; 1994 Oct; 40(4):457-65. PubMed ID: 7939418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and expression of the gene coding for IL-2(60)-PE40, a molecular targeted protein.
    Zhang M; Zhao X; Li H; Lu S
    Chin Med Sci J; 1995 Sep; 10(3):136-40. PubMed ID: 8580481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected persons.
    Ramachandran RV; Katzenstein DA; Wood R; Batts DH; Merigan TC
    J Infect Dis; 1994 Oct; 170(4):1009-13. PubMed ID: 7930696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
    Berger EA; Clouse KA; Chaudhary VK; Chakrabarti S; FitzGerald DJ; Pastan I; Moss B
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9539-43. PubMed ID: 2480605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response.
    Volk HD; Müller S; Yarkoni S; Diamantstein T; Lorberboum-Galski H
    J Immunol; 1994 Sep; 153(6):2497-505. PubMed ID: 8077661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life.
    Zuckier LS; Chang CJ; Scharff MD; Morrison SL
    Cancer Res; 1998 Sep; 58(17):3905-8. PubMed ID: 9731501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1.
    Chen W; Bardhi A; Feng Y; Wang Y; Qi Q; Li W; Zhu Z; Dyba MA; Ying T; Jiang S; Goldstein H; Dimitrov DS
    MAbs; 2016; 8(4):761-74. PubMed ID: 26963639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
    Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
    Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale immunoaffinity purification of recombinant soluble human antigen CD4 from Escherichia coli cells.
    Wells PA; Beiderman B; Garlick RL; Lyle SB; Martin JP; Herberg JT; Meyer HF; Henderson SL; Eckenrode FM
    Biotechnol Appl Biochem; 1993 Dec; 18(3):341-57. PubMed ID: 8297511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia.
    Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I
    Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of immunotoxin-induced immunogenicity by coadministration with CTLA4Ig enhances antitumor efficacy.
    Siegall CB; Haggerty HG; Warner GL; Chace D; Mixan B; Linsley PS; Davidson T
    J Immunol; 1997 Nov; 159(10):5168-73. PubMed ID: 9366448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous presence of CD4-PE40 is required for antiviral activity against single-passage HIV isolates and infected peripheral blood mononuclear cells.
    Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1091-6. PubMed ID: 8312052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages.
    Ashorn P; Englund G; Martin MA; Moss B; Berger EA
    J Infect Dis; 1991 Apr; 163(4):703-9. PubMed ID: 2010626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.